Correction to: Efficacy, durability, and safety of faricimab up to every 16 weeks in patients with neovascular age-related macular degeneration: 1-year results from the Japan subgroup of the phase 3 TENAYA trial

Saved in:
Bibliographic Details
Published in:Japanese journal of ophthalmology 2023-05, Vol.67 (3), p.311-311
Main Authors: Mori, Ryusaburo, Honda, Shigeru, Gomi, Fumi, Tsujikawa, Akitaka, Koizumi, Hideki, Ochi, Haruka, Ohsawa, Shino, Okada, Annabelle Ayame
Format: Article
Language:English
Subjects:
Correction
Medicine
Medicine & Public Health
Ophthalmology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0021-5155
1613-2246
DOI:10.1007/s10384-023-00996-7